Status:
COMPLETED
Vascular Risk After Kidney Transplantation
Lead Sponsor:
University of Nebraska
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Cardiovascular Disease
Chronic Kidney Disease
Eligibility:
All Genders
19+ years
Brief Summary
Hypothesis: Nontraditional risk factors, such as inflammation, vitamin D deficiency, elevated PTH, insulin resistance, homocysteine, or uric acid, contribute to cardiovascular disease progression afte...
Detailed Description
Cardiovascular disease remains the greatest cause of mortality after kidney transplant. Traditional risk factors, such as hypertension, diabetes, hyperlipidemia and smoking, contribute to vascular dis...
Eligibility Criteria
Inclusion
- Kidney transplant more than 6 months ago
- 19 years or older
Exclusion
- Estimated GFR \<30
- Previous small bowel, or lung transplant
- Pancreas transplant less than 6 months ago
- Cancer or any condition that would change weight dramatically in the near future such as malabsorption.
- Willing to return for testing annually for 3 years
- Women who are pregnant
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2023
Estimated Enrollment :
338 Patients enrolled
Trial Details
Trial ID
NCT00374595
Start Date
April 1 2006
End Date
June 20 2023
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198